Strive
Device Facts
| Record ID | K153704 |
|---|---|
| Device Name | Strive |
| Applicant | Djo, LLC |
| Product Code | GZJ · Neurology |
| Decision Date | Jun 3, 2016 |
| Decision | SESE |
| Submission Type | Abbreviated |
| Regulation | 21 CFR 882.5890 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
Prescription Use: The Strive™ TENS device is used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis. It is also used as an adjunctive treatment for post-surgical and post-trauma acute pain. As a TENS device, indications are for the following conditions: - Symptomatic relief and management of chronic, intractable pain - Adjunctive treatment for post-surgical and post-trauma acute pain - Relief of pain associated with arthritis Over the Counter Use: The Strive™ TENS device is used for: -temporary relief of pain associated with sore and aching muscles due to strain from exercise or normal household and work activities. -the symptomatic relief and management of chronic, intractable pain associated with arthritis.
Device Story
Strive is a handheld TENS unit delivering electrical pulses via electrodes to cutaneous and afferent nerves for pain management. Device features two pre-installed programs (P1/SMP and P2/Frequency Modulated) based on a balanced asymmetrical biphasic waveform. P1 cycles between low and high frequencies (5-122Hz) to provide comfort; P2 uses high-frequency modulation (90-120pps). Device is battery-operated (non-removable LiPo) and inoperable while charging. Used in clinical or home environments by patients (OTC) or under physician prescription (Rx). Healthcare providers use the device to manage pain; output affects clinical decision-making by providing non-pharmacological pain relief. Benefits include symptomatic management of chronic/acute pain and muscle soreness.
Clinical Evidence
Bench testing only. No clinical data presented. Testing included electrical safety, electromagnetic compatibility, software verification per FDA guidance, usability/human factors testing per IEC 60601-1-6, and coexistence testing in RF-heavy environments.
Technological Characteristics
Handheld TENS unit; LiPo 250mAh 3.7V non-removable battery; regulated current output; balanced asymmetrical biphasic waveform. Dimensions: 49mm x 64mm x 14mm; Weight: 0.99 oz. Connectivity: Lead wires for electrodes. Standards: IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, IEC 60601-2-10. Microcontroller-based control.
Indications for Use
Indicated for symptomatic relief/management of chronic, intractable pain, pain associated with arthritis, and adjunctive treatment for post-surgical/post-trauma acute pain. Also indicated for OTC use for temporary relief of pain from sore/aching muscles due to exercise or household/work activities.
Regulatory Classification
Identification
A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.
Predicate Devices
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features the department's name in a circular arrangement around a symbol. The symbol consists of a stylized depiction of a human figure in profile, with three overlapping faces representing the department's focus on health and human well-being. The logo is in black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
June 3, 2016
DJO, LLC Rand Daoud Regulatory Affairs Specialist III 1430 Decision St. Vista, CA 92081
Re: K153704
Trade/Device Name: Strive™ Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: Class II Product Code: GZJ, NUH, NYN Dated: April 21, 2016 Received: April 22, 2016
Dear Rand Daoud:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
{1}------------------------------------------------
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
# Michael J. Hoffmann -A
- for Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
### Indications for Use
510(k) Number (if known) K153704
Device Name
Strive™M
#### Indications for Use (Describe)
Prescription Use:
The Strive™ TENS device is used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis. It is also used as an adjunctive treatment for post-surgical and post-trauma acute pain.
As a TENS device, indications are for the following conditions:
- Symptomatic relief and management of chronic, intractable pain
- Adjunctive treatment for post-surgical and post-trauma acute pain
- Relief of pain associated with arthritis
Over the Counter Use:
The Strive™ TENS device is used for:
-temporary relief of pain associated with sore and aching muscles due to strain from exercise or normal household and work activities.
-the symptomatic relief and management of chronic, intractable pain associated with arthritis.
| Type of Use (Select one or both, as applicable) |
|------------------------------------------------------------------------------------------------------------------------------------|
| <span style="font-size: 10pt;"> <span style="font-family: Symbol;">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) </span> |
| <span style="font-size: 10pt;"> <span style="font-family: Symbol;">☑</span> Over-The-Counter Use (21 CFR 801 Subpart C) </span> |
CONTINUE ON A SEPARATE PAGE IF NEED
# CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
# Section 5:
# 510(k) Summary
{4}------------------------------------------------
#### Section 5. 510(k) Summary
This 510(k) summary of safety and effectiveness is being submitted in accordance with the requirements of 21 CFR 807.92.
The assigned 510(k) number is K153704.
| Submitted by: | DJO, LLC<br>1430 Decision Street<br>Vista, CA 92081 |
|------------------------|---------------------------------------------------------------------------------|
| Contact Person: | Rand Daoud<br>Regulatory Specialist III<br>760-734-3037 |
| Date Summary Prepared: | December 23, 2015 |
| Trade Name: | Strive™ |
| Classification Name: | Transcutaneous electrical nerve stimulator for pain relief<br>(21 CFR 882.5890) |
| Product Code: | GZJ (primary code)<br>NUH (primary code)<br>NYN (subsequent code) |
| Regulatory Class: | Class II |
| Predicate Device: | EMPI Select (K061650)<br>EMPI Phoenix (K124016)<br>SmartRelief (K131159) |
#### Device Description:
The Strive device is a handheld Transcutaneous Electrical Nerve Stimulation (TENS) unit which delivers electrical pulses transmitted by electrodes to cutaneous (surface) and afferent (deep) nerves of the body for pain management. The device provides simple user interface and programming, and is aimed to be used with lead wires and electrodes. Strive will be marketed as either Prescription (RX for U.S. Only) or Over-the-Counter (OTC), with each configuration having its own set of labeling, as appropriate.
The Strive device utilizes electrodes which are single patient use only. The device embeds a rechargeable battery that cannot be removed. The device is inoperable while the battery is charging.
{5}------------------------------------------------
#### Indications for Use:
Prescription Use:
The Strive device is used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis. It is also used as an adjunctive treatment for post-surgical and post- trauma acute pain.
As a TENS device, indications are for the following conditions: -Symptomatic relief and management of chronic, intractable pain -Adjunctive treatment for post-surgical and post-trauma acute pain -Relief of pain associated with arthritis
Over-the-Counter Use:
The Strive TENS device is used for:
-Temporary relief of pain associated with sore and aching muscles due to strain from exercise or normal household and work activities.
-The symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis.
#### Programs:
Strive provides two different TENS programs (P1 and P2) based on the same waveform: a balanced asymmetrical biphasic waveform that has nominally constant current in the positive phase and a second logarithmic waveform which decreases current in the negative phase. These programs are pre-installed in the Strive device and can be used interchangeably based on physician prescription (under RX use) and/or provided device program selection instructions (under OTC use).
The following is a description of programs P1 and P2:
#### SMP program (P1)
The SMP program combines two pain relief principals, High Frequency TENS and Low Frequency TENS. P1 delivers a group of pulses as a repeating 12-second cycle varies from low frequencies to high frequencies. Within each cycle, the rate and duration of the pulses vary as shown in Figure 11.2 below. The frequency varies from 5Hz to 122Hz and the pulse duration varies from 300us (at low frequencies) to 70us (at high frequencies).
The program is built to provide at the time high frequency TENS (during 9.5s of total period) and low frequency TENS (during 2.5s of total period). The pulse duration variation is done to avoid strong contraction during 12s cycle and thus increase usage comfort.
#### Frequency modulated TENS program (P2)
The modulated TENS program relies solely on the first principle of pain relief, High Frequency TENS, for the treatment of post-surgical or chronic pain.
{6}------------------------------------------------
This program has a frequency modulation range of 90 to 120pps, and a period of 4s cycle times, with a fixed pulse duration of 80us.
#### Comparison to the Predicate Devices:
The indications for use for Strive are identical to those of the predicate devices, EMPI Select, EMPI Phoenix and SmartRelief.
The technological characteristics of the device to the predicate devices are very similar, although there are a few minor differences.
The following tables summarize the similarities and differences between the technological characteristics of the devices.
| Table 1a: Basic Device Characteristics - Comparison with Predicate Rx Devices | |
|-------------------------------------------------------------------------------|--|
|-------------------------------------------------------------------------------|--|
| Characteristic | New Device | Predicate Device | Predicate Device | Same / Different |
|---------------------|--------------------------------------------------------------------------------|---------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|------------------|
| 510(k) Number | K153704 | K061650 | K124016 | NA |
| Device Name | Strive | EMPI Select | EMPI Phoenix | NA |
| | -Symptomatic<br>relief and<br>management of<br>chronic, intractable<br>pain. | -Symptomatic relief and<br>management of chronic,<br>intractable pain. | As a TENS device,<br>indications are for<br>the following<br>conditions: | |
| Indications for Use | -Adjunctive<br>treatment for post-<br>surgical and post-<br>trauma acute pain. | -Adjunctive treatment for<br>post-surgical and post-<br>trauma acute pain | -Symptomatic relief<br>and management of<br>chronic, intractable<br>pain<br>-Adjunctive<br>treatment for post-<br>surgical and post-<br>trauma acute pain | Similar |
| | -Relief of pain<br>associated with<br>arthritis. | -Relief of pain associated<br>with arthritis. | -Relief of pain<br>associated with<br>arthritis | |
{7}------------------------------------------------
| Prescription/OTC | Prescription | Prescription | Prescription | Same |
|--------------------------------------------------|---------------------------------------------|-----------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------|
| TENS Programs | SMP Mode<br>(SMP) | Strength Duration (SD) | Frequency<br>Modulated<br>TENS (FM) | Similar |
| | Frequency<br>Modulation<br>(FM) | Alternating Ramped<br>Burst (ARB), | | SMP for<br>Strive<br>and<br>Select are<br>the same. |
| | | SMP Mode (SMP) | | |
| | | Modulation Amplitude<br>(MA), | | FM for<br>Strive<br>and<br>Phoenix<br>are same. |
| | | Continuous (C),<br>Cycled Burst (B),<br>Modulation (M). | | |
| Connection of device<br>to electrodes | Lead wires | Lead wires | Leadwires and<br>garment | Same |
| Power Source(s) | LiPo 250[mAh]<br>(3.7[V]), not<br>removable | Alkaline or<br>Rechargeable (3 AAA) | 2 AA LR06<br>Batteries, 1.5 V<br>Alkaline or 1.2<br>V NiMh<br>rechargeable | Different |
| - Method of line<br>current isolation | N/A<br>(battery operated<br>device) | N/A<br>(battery operated<br>device) | N/A<br>(battery<br>operated device) | Same |
| - Patient Leakage<br>Current | N/A<br>(battery operated<br>device) | N/A<br>(battery operated<br>device) | N/A<br>(battery<br>operated device) | Same |
| ● Normal condition | N/A<br>(battery operated<br>device) | N/A<br>(battery operated<br>device) | N/A<br>(battery<br>operated device) | Same |
| • Single fault<br>condition | N/A<br>(battery operated<br>device) | N/A<br>(battery operated<br>device) | N/A<br>(battery<br>operated device) | Same |
| Number of Output<br>Modes | 2(2xTENS) | 7 (7xTENS) | 4 (1xTENS,<br>2xNMES,<br>1xPulsed<br>Current DC) | Different |
| Number of Output<br>Channels | 1, split | 2 | 2 | Similar |
| - Synchronous or<br>Alternating? | NA | Program dependent | Synchronous<br>but never two<br>channels<br>activated at the<br>same time | Different |
| - Method of Channel<br>Isolation | NA | Transformer | Each channel is<br>the middle of an<br>H Bridge.<br>Except when it<br>is activated,<br>each channel is<br>in high<br>impedance state. | Different |
| Regulated Current or<br>Regulated Voltage? | Regulated<br>Current | Constant voltage pulse,<br>constant current<br>undershoot | Regulated<br>Current | Different |
| Software/Firmware/<br>Microprocessor<br>Control? | Yes,<br>Microcontroller | Yes, Microprocessor | Yes. | Same |
| Automatic Overload<br>Trip? | No | No | No | Same |
| Automatic No-Load<br>Trip? | Yes | Yes | Yes | Same |
| Automatic Shut Off? | Yes | Yes | Yes | Same |
| Patient Override<br>Control? | No | No | Yes (On/Off<br>switch) | Different |
| Indicator Display<br>- On/Off Status? | Yes (P1 & P2,<br>Output<br>Indicators) | Yes (LCD) | Yes | Same |
| - Low Battery? | No | Yes. Battery icon on<br>LCD. | Yes | Different |
| - Voltage/Current<br>Level? | Active/inactive<br>output | Yes, numeric value on<br>LCD | Yes | Different |
| Timer Range<br>(minutes) | Unlimited | Unlimited | 20 minutes (P1<br>and P2),<br>30 minutes (P4),<br>Unlimited (P3) | Similar |
| Compliance with 21<br>CFR 898? | Yes | Yes | Yes | Same |
| Weight | 0.99 oz | 4.9 oz with batteries | 170 g with<br>batteries | Different |
| Dimensions [W x H x<br>D] | 49 mm x 64mm x<br>14 mm | 109mm x 61mm 36 mm | 67mm x 135mm<br>x 30mm | Different |
{8}------------------------------------------------
{9}------------------------------------------------
### Table 1b: Basic Device Characteristics – Comparison with Predicate OTC Device
| Characteristic | New Device | Predicate Device | Same /<br>Different |
|----------------|------------|------------------|---------------------|
| 510(k) Number | K153704 | K131159 | NA |
| Device Name | Strive | SmartRelief | NA |
| Manufacturer | DJO, LLC. | Chattem, Inc. | NA |
{10}------------------------------------------------
| Indications for Use | -Temporary relief of pain<br>associated with sore and<br>aching muscles due to<br>strain from exercise or<br>normal household and<br>work activities.<br>-The symptomatic relief<br>and management of<br>chronic, intractable pain<br>and relief of pain<br>associated with arthritis. | -Temporary relief of pain<br>associated with sore and<br>aching muscles due to<br>strain from exercise or<br>normal household and<br>work activities.<br>-The symptomatic relief<br>and management of<br>chronic, intractable pain<br>and relief of pain<br>associated with arthritis. | Same |
|--------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
| Prescription/OTC | OTC | OTC | Same |
| TENS Programs | SMP Mode (SMP)<br>Frequency Modulation<br>(FM) | TENS (SMP) | Similar |
| Connection of device<br>to electrodes | Lead wires | Snaps on the device | Different |
| Power Source(s) | LiPo 250[mAh] (3.7[V]),<br>not removable | Lithium Battery<br>Coin cell CR2032 3V | Different |
| - Method of line<br>current isolation | N/A<br>(battery operated device) | N/A (battery<br>operated device) | Same |
| - Patient Leakage<br>Current | N/A<br>(battery operated device) | N/A (battery<br>operated device) | Same |
| ● Normal condition | N/A<br>(battery operated device) | N/A (battery<br>operated device) | Same |
| ● Single fault<br>condition | N/A (battery operated<br>device) | N/A (battery<br>operated device) | Same |
| Number of Output<br>Modes | 2(2xTENS) | 1 (TENS) | Different |
| Number of Output<br>Channels | 1, split | 1 | Similar |
| | | | |
| - Synchronous or<br>Alternating? | NA | NA | Same |
| - Method of Channel<br>Isolation | NA | NA | Same |
| Regulated Current or<br>Regulated Voltage? | Regulated Current | Regulated Current | Same |
| Software/Firmware/<br>Microprocessor<br>Control? | Yes, Microcontroller | Yes, micro controller | Same |
| Automatic Overload<br>Trip? | No | No | Same |
| Automatic No-Load<br>Trip? | Yes | No | Different |
| Automatic Shut Off? | Yes | Yes | Same |
| Patient Override<br>Control? | No | No | Same |
| Indicator Display<br>- On/Off Status? | Yes (P1 & P2, Output<br>Indicators) | Yes | Same |
| - Low Battery? | No | No | Same |
| Voltage/Current<br>Level? | Active/inactive output | Active/inactive<br>output | Same |
| Timer Range<br>(minutes) | Unlimited | Yes (30min) | Different |
| Compliance with 21 CFR 898? | Yes | Yes | Same |
| Weight | 0.99 oz | 20g (0.7oz) | Different |
| Dimensions [W x H x D] | 49 mm x 64mm x 14 mm | 64x38x13[mm] (2.5x1.5x0.5["]) | Different |
{11}------------------------------------------------
{12}------------------------------------------------
# Table 2: Output Specifications – Comparison with EMPI Select Predicate Device
| Characteristic | New Device | Predicate Device<br>(EMPI Select) | Same/<br>Different |
|----------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|--------------------|
| Output mode / Program | P1 (SMP) | SMP | Same |
| Waveform | Balanced,<br>Asymmetrical Biphasic | Balanced, Asymmetrical<br>Biphasic | Same |
| Shape | Square positive pulse,<br>current controlled<br>Logarithmic negative<br>pulse, decrease current. | AC, constant current<br>undershoot; constant voltage<br>pulse | Different |
| Maximum Output<br>Voltage (± 10%) | 110[V] peak on 10[kΩ]<br>110[V] peak on 2[kΩ]<br>60[V] peak on 1[kΩ]<br>30[V] peak on 500[Ω] | 0[V] (open lead) peak on<br>10[kΩ]<br>40[V] peak on 2[kΩ]<br>30[V] peak on 1[kΩ]<br>30[V] peak on 500[Ω] | Different |
| Maximum Output<br>Current (± 10%) | 11[mA] peak on<br>10[kΩ]<br>55[mA] peak on 2[kΩ]<br>60[mA] peak on 1[kΩ]<br>60[mA] peak on<br>500[Ω]<br>Max rms current<br>6.28[mA]rms<br>(divided by 2 per output<br>when split) | 0[mA] (open lead) peak on<br>10[kΩ]<br>20[mA] peak on 2[kΩ]<br>30[mA] peak on 1[kΩ]<br>60[mA] peak on 500[Ω]<br>Max rms current 11[mA]rms | Same |
| Pulse Width | 70 to 300[μs]<br>(measured at 50% of<br>positive pulse) | 0-400 μs at 50%<br>of peak<br>amplitude | Similar |
| Frequency | 5 to 122[Hz] | 2, 5-150 Hz, 5Hz increments | Similar |
| For multiphasic waveforms only:<br>- Symmetrical phases?<br>- Phase Duration (include units) (state range, if applicable) (both phases, if asymmetrical) | Biphasic:<br>Asymmetrical<br>70 to 300[µs] for positive pulse, logarithmic negative pulse, decrease current. | Biphasic:<br>Asymmetrical<br>0 to 400[µs] for positive pulse, constant current undershoot | Same |
| Net Charge [µC/pulse] | 18[µC] on 1[kΩ] | 12[µC] / output on 1 [kΩ] load<br>(24[µC] CH1 & 2 together) | Different |
| Maximum Phase Charge [µC] | 0[µC] on 1[kΩ] | 0[µC] / output on 1 [kΩ] load | Same |
| Maximum Current (RMS) Density [mA/cm²] | 0.31[mA/cm²] (over 1[s] period) | 11 [mA] | Same |
| Maximum Power Density [mW/cm²] | 4.92[mW/cm²] (split on 2x1[kΩ] in //) | 44[mW/cm²] per output, on 1[kΩ] | Different |
| Burst Mode (i.e. pulse trains)<br>a) Pulses per burst<br>b) Bursts per second<br>c) Burst duration (seconds)<br>d) Duty Cycle [Line (b) x Line (c)] | NA, no burst mode | a) 29[pulses/burst]<br>b) 0.39[burst/s]<br>c) 1.9[s] | Different |
| ON Time (seconds) | Once started, the output is active until user manually stops the unit | Depends on the selected program | Different |
| OFF Time (seconds) | NA, no OFF time | Depends on the selected program | Different |
| Additional Features (if applicable) | NA, no additional feature | NA, no additional feature | Same |
{13}------------------------------------------------
{14}------------------------------------------------
| Characteristic | New Device | Predicate Device<br>(EMPI Phoenix) | Similar/<br>Different |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------|
| Output mode / Program | P2 (Frequency Modulated<br>TENS) | Frequency Modulated<br>TENS (P3) | Same |
| Waveform | Balanced, Asymmetrical<br>Biphasic | Symmetrical Biphasic | Similar |
| Shape | Square positive pulse,<br>current controlled<br>Logarithmic negative<br>pulse, decrease current. | Rectangular | Different |
| Maximum Output<br>Voltage (± 10%) | 110[V] peak on 10[k[Ω]]<br>110[V] peak on 2[k[Ω]]<br>60[V] peak on 1[k[Ω]]<br>30[V] peak on 500[Ω] | 150[V] peak on 10[k[Ω]]<br>150[V] peak on 2[k[Ω]]<br>100[V] peak on 1[k[Ω]]<br>50[V] peak on 500[Ω] | Different |
| Maximum Output<br>Current (± 10%) | 11[mA] peak on 10[k[Ω]]<br>55[mA] peak on 2[k[Ω]]<br>60[mA] peak on 1[k[Ω]]<br>60[mA] peak on 500[Ω]<br>Max rms current<br>6.28[mA]rms<br>(divided by 2 per output<br>when split) | 15[mA] peak on<br>10[k[Ω]]<br>75[mA] peak on 2[k[Ω]]<br>100[mA] peak on<br>1 [k[Ω]]<br>100[mA] peak on<br>500[Ω]<br>Max rms current<br>21.2[mA]rms | Different |
| Pulse Width | 80[µs] (measured at<br>50% of positive pulse) | 80µs | Same |
| Frequency | 90 to 120[Hz] | 90-120 Hz | Same |
| For multiphasic<br>waveforms only:<br>Symmetrical phases?<br>-<br>Phase Duration<br>-<br>(include units) (state<br>range, if applicable)<br>(both phases, if<br>asymmetrical) | Biphasic:<br>Asymmetrical<br>-<br>70 to 300[us] for<br>-<br>positive pulse,<br>logarithmic negative<br>pulse, decrease<br>current. | NA | Different |
| Net Charge<br>[µC/pulse] | 18[µC] @ 500[Ω] | 30 µC @ 500Ω | Different |
| Maximum Phase Charge<br>[μC] | 0[µC] on 1[kΩ] | 0[µC] / output on 1<br>[kΩ] load | Same |
| Maximum Current (RMS)<br>Density [mA/cm²] | 0.33[mA/cm²]<br>(over 1[s] period) | 1.44 mA/ cm²@ 500Ω | Different |
| Maximum Power Density<br>[mW/cm²] | 5.53[mW/cm²] @ 500[Ω] | 0.0111W/cm² @ 500Ω | Different |
| Burst Mode (i.e. pulse<br>trains)<br>e) Pulses per burst<br>f) Bursts per second<br>g) Burst duration (seconds)<br>h) Duty Cycle [Line (b) x<br>Line (c)] | NA, no burst mode | NA | Same |
| ON Time (seconds) | Once started, the output<br>is active until user<br>manually stops the unit | Constant (without<br>handswitch) | Different |
| OFF Time (seconds) | NA, no OFF time | 0 (without<br>handswitch) | Different |
| Additional Features (if<br>applicable) | NA, no additional feature | NA | Same |
# Table 3: Output Specifications – Comparison with EMPI Phoenix Predicate Device
{15}------------------------------------------------
# Table 4: Output Specifications – Comparison with Chattem SmartRelief Predicate Device
| Characteristic | New Device | Predicate Device<br>(SmartRelief) | Similar/<br>Different |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|-----------------------|
| Output mode /<br>Program | P1 (SMP) | TENS (SMP) | Similar |
| Waveform | Balanced, Asymmetrical<br>Biphasic | Balanced, Asymmetrical<br>Biphasic | Similar |
| Shape | Square positive pulse,<br>current controlled<br>Logarithmic negative pulse,<br>decrease current. | Square positive pulse,<br>current controlled<br>Logarithmic negative<br>pulse, decrease current. | Similar |
| Maximum Output<br>Voltage (± 10%) | 110[V] peak on 10[kΩ]<br>110[V] peak on 2[kΩ]<br>60[V] peak on 1[kΩ]<br>30[V] peak on 500[Ω] | 70[V] peak on 10[kΩ]<br>70[V] peak on 2[kΩ]<br>60[V] peak on 1[kΩ]<br>30[V] peak on 500[Ω] | Different |
| Maximum Output<br>Current (± 10%) | 11[mA] peak on 10[kΩ]<br>55[mA] peak on 2[kΩ]<br>60[mA] peak on 1[kΩ]<br>60[mA] peak on 500[Ω]<br>Max rms current<br>6.28[mA]rms<br>(divided by 2 per output<br>when split) | 7[mA] peak on 10[kΩ]<br>35[mA] peak on 2[kΩ]<br>60[mA] peak on 1[kΩ]<br>60[mA] peak on 500[Ω]<br>Max rms current<br>3[mA]rms | Similar |
| Pulse Width | 70 to 300[µs] (measured<br>at 50% of positive pulse) | 30-220 µs at<br>50% of peak<br>amplitude | Similar |
| Frequency | 5 to 122[Hz] | max 100[Hz] | Similar |
| For multiphasic<br>waveforms only:<br>Symmetrical<br>-<br>phases?<br>Phase Duration<br>(include units)<br>(state range, if<br>applicable) (both<br>phases, if<br>asymmetrical) | Biphasic:<br>Asymmetrical<br>-<br>70 to 300[µs] for<br>-<br>positive pulse,<br>logarithmic negative<br>pulse, decrease current. | Biphasic:<br>Asymmetrical<br>-<br>30 to 220[µs] for positive<br>pulse, constant<br>current<br>undershoot | Similar |
| Net Charge<br>[µC/pulse] | 18[µC] @ 1[kΩ] | 13.2[µC] | Different |
| Maximum Phase<br>Charge [µC] | 0[µC] on 1[kΩ] | 0[µC] | Similar |
| Maximum Current<br>(RMS)<br>Density [mA/cm2] | 0.31[mA/cm²]<br>(over 1[s] period) | 0.1[mA/cm²]<br>(2.06[mA]/20[cm²]) | Similar |
| Maximum Power<br>Density [mW/cm²] | 4.92[mW/cm²]<br>(split on 2x1[kΩ] in //) | 1.5[mW/cm²]<br>(60mA*70V*2*40µs *<br>90Hz) / 4.5²cm² | Different |
| Burst Mode (i.e. pulse trains)<br>i) Pulses per burst<br>j) Bursts per second<br>k) Burst duration (seconds)<br>l) Duty Cycle [Line (b) x Line (c)] | NA, no burst mode | NA, no burst mode | Same |
| ON Time (seconds) | Once started, the output is active until user manually stops the unit | 30[min] | Different |
| OFF Time (seconds) | NA, no OFF time | NA, no OFF time | Same |
| Additional Features (if applicable) | NA, no additional feature | NA, no additional feature | Same |
{16}------------------------------------------------
{17}------------------------------------------------
Although there are minor differences observed between the predicate devices and Strive, seen in the tables above, there are no differences in which raise any new questions of safety or effectiveness.
#### Performance Testing:
Electrical Safety and Electromagnetic Compatibility: Strive testing comprises of the following standards for electrical safety and electromagnetic compatibility:
- . IEC 60601-1 for basic safety and essential performance
- IEC 60601-1-2 for electromagnetic compatibility ●
- IEC 60601-1-11 for use in a home healthcare environment ●
- IEC 60601-2-10 for performance of nerve and muscle stimulators ●
Software Verification: The device's software was verified in accordance with the requirements of FDA's guidance document: General Principles of Software Validation, January 11, 2002. The software testing demonstrated that the software meets its design requirements.
Usability/Human Factors Testing: Usability/Human Factors testing was performed in accordance to standard IEC 60601-1-6, which demonstrated that the established requirements for usability were met, and the device's design is appropriate for the intended users and use environment. The result of this study substantiates the acceptability of the use-related risks identified during the risk assessment activities.
Coexistence Testing: The performance of Strive was evaluated in an environment with other devices (Bluetooth, Wi-Fi, Microwave Oven), as well as in an environment with clinical devices which intentionally and unintentionally emit RF frequencies. The device met all specified requirements.
{18}------------------------------------------------
#### Conclusion:
Based on the performance testing and the similarities of the indications for use and the technological characteristics, it can be concluded that Strive is as safe and effective as, and substantially equivalent to, the predicate devices.
